Taldenaxyl 20 Kalpa Pharmaceuticals — Research Summary
Taldenaxyl 20 is a phosphodiesterase type 5 (PDE5) inhibitor compound containing tadalafil citrate, formulated by Kalpa Pharmaceuticals specifically for laboratory research applications. This compound enables researchers to investigate the molecular mechanisms underlying PDE5 enzyme inhibition and its effects on cellular signalling pathways. Scientists can examine how this compound interacts with the cyclic guanosine monophosphate (cGMP) pathway in controlled laboratory environments. Research facilities studying vascular biology and smooth muscle physiology may find this compound valuable for their investigations. As a quality research supplier, Stroid UK Shop provides laboratory-grade compounds to support scientific advancement.
Laboratory Applications
Researchers study Taldenaxyl 20 to analyse PDE5 enzyme inhibition mechanisms in cellular models. This compound allows scientists to investigate nitric oxide signalling pathways and cGMP metabolism under controlled laboratory conditions. Vascular research applications include examining endothelial function and smooth muscle relaxation responses in tissue samples. The compound’s molecular structure makes it suitable for pharmacokinetic studies and receptor binding assays. Scientists working with erection drugs research compounds can evaluate comparative efficacy profiles across different PDE5 inhibitors. Research teams may also investigate this compound’s stability under various storage conditions. Cell culture experiments benefit from the compound’s solubility characteristics, enabling precise concentration studies. Additionally, researchers exploring SARMs or peptides may use this compound as a reference standard in comparative pharmacology studies.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Tadalafil Citrate |
| Strength | 20mg per unit |
| Manufacturer | Kalpa Pharmaceuticals |
| Form | Oral tablet |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage | Room temperature, dry conditions |
| Research Use | In-vitro laboratory studies only |
Compliance Statement
Taldenaxyl 20 is manufactured exclusively for in-vitro research purposes and is not intended for human consumption, clinical use, or therapeutic applications. This product is designed solely for qualified research institutions and laboratory professionals conducting scientific studies on PDE5 inhibition mechanisms. Researchers must ensure compliance with local regulations governing laboratory chemical handling and disposal. All studies should be conducted under appropriate laboratory safety protocols with proper documentation of research methodologies and outcomes.
